X-Vax Technology

About:

X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes.

Website: http://x-vax.com/

Top Investors: Founders Fund, Johnson & Johnson Innovation – JJDC, Alexandria Venture Investments, Serum Institute of India Pvt. Ltd., Adjuvant Capital

Description:

X-Vax Technology is a biotechnology company focused on the preclinical and clinical development of vaccines against pathogens that cause mucosal infections such as herpes, influenza, tuberculosis and HIV, affecting hundreds of millions of people around the globe. They believe that inducing antibodies that mediate the killing of infected cells will provoke an entirely new and effective immune response – so that they can finally beat these pathogens. The company was founded in 2015 and based in Jupiter, Florida.